Embecta Corp. (EMBC) fundamentals score
Embecta has a broad portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its conventional pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 7.0 out of 10, Mixed fundamentals
- Growth: 4.1/10
- Profitability: 8.1/10
- Financial health: 5.1/10
- Earnings quality: 9.9/10
- Valuation: 9.7/10
Scores are calculated from Embecta Corp.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10